Identity
- Security key
- 16440
- Ticker
- HCWB
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2021-07-20
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- HCWB
Detail
Enriched 2026-08-14 20:47
- Market cap
- $5,022,086.96
- Shares outstanding (class)
- 1,596,849
- Shares outstanding (weighted)
- 1,596,848
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 35
- Location
- MIRAMAR, FL
- Homepage
- https://www.hcwbiologics.com
- Description
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.